Search

everythinglearnresearchcommunity

for

Search:↓

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Women are more likely to have long-term post-COVID symptoms than men.

Allogenic ASCs and ECM transplants are safe and effective for tissue regeneration.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

Long COVID is complex, affects many survivors, and needs more research for effective treatments.

Proper mTOR signaling is crucial for healthy skin and preventing skin diseases.

Enhancing antioxidant responses can improve treatments for various diseases.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Natural products may be safer and effective alternatives for managing heart attacks.

Damaged skin has a weakened barrier, making it more vulnerable to substances and inflammation.

Mesenchymal stem cells could help treat diabetes and its complications by improving insulin function and reducing inflammation.

South African wild foods may help prevent cardiovascular disease.

Researchers converted human embryonic stem cells into trophoblast stem cells using specific transcription factors.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.